IL-6 induces the ERK pathway to regulate the differentiation and activation of T lymphocytes and is a cytokine that has recently been targeted for treating chronic inflammatory diseases such as asthma and rheumatoid arthritis [33]. Here, IL6 is linked to rheumatoid arthritis.